fda warning compounding semaglutide september 2025 Compounded & Tirzepatide 2025: Safe Use Guide Congress Introduces SAFE Drugs Act

Inflamm Bowel Dis (2010) 16(6):96273.10.1002/ibd.21117 178 JeppesenPBGilroyRPertkiewiczMAllardJPMessingBOKeefeSJ

GLP-1 receptor agonists have transformed weight loss treatment, helping patients lose 15-22% of body weight in clinical trials

Shown to support up to 22% weight loss in clinical studies, higher than Semaglutide Not recommended for individuals with a history of medullary thyroid cancer or pancreatitis

Suppliers who maintain affiliations with professional organisations, research institutions, or industry groups often demonstrate higher standards of quality and compliance

"There are all kinds of reasons people will choose not to take these drugs, but there's a tremendous amount of pressure to take them, whether you think they are safe or not," Osborn said